Koordination und Qualität im Gesundheitswesen

Bundesverband der Betriebskrankenkassen (2003): Evaluation der BKK-Pharmakotherapieberatung
in Kooperation mit der KV Nordrhein – Erste bis dritte Beratungswelle, Essen.
Butzlaff, M., Floer, B. and Isfort, J. (2003): ‚Shared decision making‘: Der Patient im Mittelpunkt
von Gesundheitswesen und Praxisalltag? In: Böcken, J., Braun, B., Schnee, M.
(Hrsg.): Gesundheitsmonitor 2003, Bertelsmann Stiftung, Gütersloh, S. 41-55.
Calfee, J. E. (2003): What do we know about direct-to-consumer advertising of prescription
drugs? Health Affairs, Web Exclusive, W3-117, www.healthaffairs.org.
Carthy, P., Harvey, I., Brawn, R., Watkins, C. (2000): A study of factors associated with cost
and variation in prescribing among GPs. Family Practice, Vol. 17, S. 36-41.
Cassels, A., Hughes, M.A., Cole, C., Mintzes, B., Lexchin, J., and McCormack, J.P. (2003):
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
Canadian Medical Association Journal, Vol. 168, S. 1133-1137.
Caudill, T.S., Johnson, M.S., Rich, E.C., McKinney, W.P.(1996): Physicians, pharmaceutical
sales representatives, and the cost of prescribing. Archive of Family Medicine, Vol. 5,
S. 201-206.
Chan, A.-W., Hróbjartsson, A., Haahr, M.T., Gøtzsche, P.C., and Altman, D.G. (2004): Empirical
evidence for selective reporting of outcomes in randomized trials. Comparison of protocols
to publishes articles. Journal of the American Medical Association, Vol. 291, S. 2457-
2465.
Chan, M., Nicklason, F. and Vial, J.H. (2001): Adverse drug events as a cause of hospital
admission in the elderly. Internal Medicine Journal, Vol. 31, S. 199-205.
Chernew, M., Cowen, M.E., Kirking, D.M., Smith, D.G., Valenstein, P. and Fendrick, A.M.
(2000): Pharmaceutical Cost Growth und Capitation: A case study. Health Affairs, Vol. 19,
Nr. 6, S 266-276.
Cho, M.K. and Bero, L.A. (1996): The quality of drug studies published in symposium proceedings.
Annals of Internal Medicine, Vol. 124, S. 485-489.
Cleland, J.G., Cohen-Solal, A., Aguilar, J.C., Dietz, R., Eastaugh, J., Follath, F., Freemantle, N.,
Gavazzi, A., van Gilst, W.H., Hobbs, F.D., Korewicki, J., Madeira, H.C., Preda, I.,
Swedberg, K. and Widimsky, J. (2002): Management of heart failure in primary care (the
IMPROVEMENT of heart failure programme): an international survey. Lancet, Vol. 360,
S. 1631-1639.
Cochrane Netzwerk Deutschland (2004): Registrierung klinischer Studien. Rundbrief Nr. 12,
Dezember 2004, S. 2-3.
Coscelli, A. (2000): The importance of doctors‘ and patients‘ preferences in the prescription decision.
Journal of Industrial Economics, Vol. 48, S. 349-369.
Dahlof, B., Devereux, R.B., Kjeldsen, S.E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F.,
Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., Lindholm, L.H., Nieminen, M.S.,
Omvik, P., Oparil, S. and Wedel, H. (2002): Cardiovascular morbidity and mortality in the
Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised
trial against atenolol. Lancet, Vol. 359, S. 995-1003.
Damoiseaux, R.A.M.J., de Melker, R.A., Ausems, M.J.E., and van Balen, F.A.M. (1999) : Reasons
for non-guideline-based antibiotic prescriptions for acute otitis media in The Netherlands.
Family Practice, Vol. 16, S. 50-53.
743